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Sumrnurn The viability of cells within the acidic microenvironment found in solid tumours is expected to
depend on the regulation of intracellular pH (pH). 5-(N.N-hexamethylene) amiloride (HMA) is a potent
inhibitor of the Na- H' antiport. a major mechanism for the regulation of pH. We have therefore studied the
cytotoxicity of HMA in combination with nigericin, a cell-acidifying agent. for EMT-6 cells in monolayer cell
culture. in spheroids and in a murine tumour model. The combination of nigericin and HMA was toxic to cells
in tissue culture at extracellular pH (pH,) < 6.8 (as may be found in tumours) but not at pH 7.0 or above (as
in most normial tissues). Compared with amiloride. the relative potency of HMA in causing in vitro
cytotoxicity (- 100-fold) was similar to that for inhibition of the Na+ H+ antiport. The fluorescent probe
Hoechst 33342 was used with flow cytometry to study the cytotoxicity of HMA and nigericin at different
depths in multicellular tumour spheroids. Only small differences in the level of cell survival were observed, but
higher concentrations of HMA were required as compared with those giving equal levels of survival in
monolayer culture. The pharmacokinetics of HMA in mice was studied by using high-performance liquid
chromatography: after intraperitoneal injection of 20 Lg g-'. the plasma level of HMA peaked at 8 iLm after
about 15 min and decreased to I gM at 120 min the half-life was 35 min. Nigericin and HMA. at doses of
1.25 gg-' and 10 ug g-' respectively. failed to cause significant cell killing in the EMT-6 murine tumour, but
the surviving fraction was reduced to- 0.004 when hydralazine was administered With nigericin and HMA.
Local tumour irradiation (15 Gy). followed by treatment with these drugs. led to cell killing that was additive
to the effects of drugs and radiation alone, so that hypoxic cells which survived radiation did not appear more
sensitive to pH-dependent drug treatment. Acid-mediated therapy can lead to cell death in murine solid
tumours. but further measures will be required before the strategy can be exploited clinically.
The microenvironment of solid tumours is often different
from that of normal tissues in that the extracellular pH (pH.)
of tumours tends to be lower than in normal tissues (Wike-
Hooley et al.. 1984; Vaupel et al.. 1989). To maintain their
intracellular pH (pH,) at or near physiological levels in the
face of a chronic acid load. the survival of tumour cells is
likely to depend on mechanisms responsible for the regula-
tion of pH,. since most cellular processes require an optimal
pH at or near the physiological level (Busa & Nuccitelli,
1984). Two major membrane-based ion transport systems are
involved in the regulation of pH-: the amiloride-sensitive
Na+ H+ antiport (Grinstein et al., 1989) and the stilbene-
sensitive Na+-dependent Cl- HCO3- exchanger (Cassel et
al.. 1988). The Na,H' antiport, a 110 kDa membrane pro-
tein, is ubiquitous in mammalian cells. The antiport uses the
inwardly directed Na+ gradient. which is maintained by the
Na+. K+-ATPase, to pump H+ out of the cells. In addition
to the regulation of pH,. the Na' H+ antiport also par-
ticipates in mitogenesis (Grinstein et al., 1989) and in the
control of cell volume (Rotin & Grinstein, 1989). The Na+-
dependent Cl- HCO3- exchanger uses the inwardly directed
Na+ gradient to exchange intracellular Cl- for extracellular
HCO,-, which can then buffer intracellular H+ (Cassel et al..
1988; Reinertsen et al.. 1988).
The results of experiments performed in tissue culture
suggest that under the microenvironmental conditions found
within the acidic regions of solid tumours, the Na+/H+
exchanger is probably the major mechanism for regulation of
pHi (Boyer & Tannock, 1992). Studies using variant Na',+
exchange-deficient human bladder cancer cells revealed that
these cells had a marked decrease in their ability to form
tumours in immune-deficient mice, and tumours that did
grow appeared to contain revertant cells. These results sug-
gest that the Na+/H+ antiport may be required for the
growth of solid tumours (Rotin et al., 1989), and support the
hypothesis that the Na+/H+ antiport is an appropriate target
for tumour-selective therapy.
Amiloride and some of its analogues have been shown to
inhibit the Na+ H+ antiport (Cragoe et al.. 1967; L'Allemain
et al., 1984; Kleyman & Cragoe. 1988). The most potent and
specific inhibitors of the Na+ H+ antiport are amiloride
analogues with hydrophobic substitutions on the 5-amino
group (Kleyman & Cragoe, 1988). Examples are EIPA [5-(N-
ethyl-N-isopropyl) amiloride] and HMA [5-(N,,-hexa-
methylene) amilon'de], which have been reported to be about
200 to 500-fold more potent than amiloride (Simchowitz &
Cragoe, 1986). There is also evidence that HMA is stable in
rat plasma (Meng et al.. 1990).
The difference in level of pH, between solid tumours and
normal tissues provides an opportunity for tumour-selective
therapy. Previous studies have indicated that ionophores
which acidify cells [e.g. nigericin or carbonylcyanide-3-
chlorophenylhydrazone (CCCP)] caused pH,-dependent
cytotoxicity in vitro, and this cycotoxicity was increased by
amiloride and its analogues (Rotin et al.. 1987; Newell &
Tannock, 1989; Maidorn et al., 1993). Results from in vivo
experiments using murine tumour models have indicated that
nigenrcin and amiloride given with hydralazine to reduce
tumour blood flow can kill tumour cells (Newell et al.. 1992).
This effect might be amplified by using analogues of
amiloride that are more potent inhibitors of Na+ H+
exchanger activity.
Since HMA is a very potent inhibitor of the Na+ H+
antiport and appears also to be quite stable to metabolism.
we have examined its potential in tumour-selective therapy.
First, HMA was examined for its ability to inhibit Na+ H+
antiport activity. Secondly. its in vitro cytotoxicity was deter-
mined in terms of dose response, influence of exposure time
and permissive range of pH, using single cells in culture.
Subsequently, the tissue penetration of HMA was studied in
EMT-6 spheroids by comparing cell killing in intact and
dissociated spheroids and by examining cell-killing as a func-
tion of penetration in spheroids by using Hoechst 33342
staining and flow cytometry. The pharmacokinetics of HMA
was also studied in mice. Finally, the anti-tumour effects of
HMA were studied using a murine tumour model, alone, in
the presence or absence of hydralazine, and with or without
local tumour radiation.
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Materials and methods the ratio of plating efficiency (PE) of the treated to that of
untreated controls.
Cells
Most expenrments were performed with EMT-6 cells (a
munne sarcoma line. obtained onrginallv from R. Sutherland.
Rochester. NY. USA). Munrne KHT cells were also used in a
few experiments. Cells were maintained in cx-MEM sup-
plemented With 5100 fetal calf serum (FCS) (10% for KHT)
and 0.1 mg ml-' kanamycin. New cultures. free of myco-
plasma. were re-established from frozen stock after approx-
imately 29 passages.
Reagents
Amiloride. nigericin and hydralazine were purchased from
Sigma (St Louis. MO. USA). HMA was provided initially by
E. Cragoe (PO Box 631548. Nacogdoches. TX. USA). and
subsequently by Research Biochemical Incorporated (RBI)
(Natick. MA. USA). EIPA and Hoechst 33342 were obtained
from Aldnrch (Milwaukee. WI. USA). benzamile from RBI.
and ''.7'-bis-(2-carboxyethyl)-5-(and 6)-carboxy-fluorescein
acetoxymethyl ester (BCECF-AM) from Molecular Probes
(Eugene. OR. USA).
Stock solutions of amiloride and hydralazine were
prepared by dissolving them in distilled water. EIPA was
dissolved in 4% DMSO. HMA and BCECF-AM in 100%
DMSO, and nigericin in 100% ethanol. Stock solutions were
diluted in phosphate-buffered saline (PBS) prior to injection
into mice in in vivo experiments. Hoechst 33342 was dissolved
in PBS and adjusted to its final concentration with double-
distilled water.
Quantitation ofNa- H-antiport actiuitsi
The pH-sensitive fluorescent dye BCECF-AM was used to
measure pH,. At an excitation wavelength of 495 nm. the
fluorescence emission at 525 nm of BCECF is linearly related
to pH, in the range 6.0-7.6 (Rink et al.. 1982: Musgrove et
al.. 1986). There was no measurable leakage of dye during
the course of the experiments.
A fluoresence spectrophotomer (Perkin Elmer model LS3.
Mississauga. Ontario. Canada) was used to measure pH,.
Exponentially growing cells were detached from flasks.
incubated with BCECF-AM and placed in a cuvette contain-
ing 1.8 ml of Na-- and HCO,--free NV-methyl-E-glucamine
(NMG) as described previously (Maidorn et al.. 1993).
Nigericin. an ionophore which exchanges intracellular K' for
extracellular H+. was added to the cuvette to acidify the cells.
Albumin was added to bind excess nigericin. Sodium chloride
was then added (to a final concentration of 100 mM). thus
allowing cells to use the Na+ H+ antiport to raise their pHi.
The rate of increase of pH, (as recorded by fluorescence
emission) is a direct measure of the activity of the antiport.
In the presence of amiloride or its analogues, the rate of
increase ofpH, is inhibited and the percentage inhibition was
measured (by determining the ratio of the inhibited slope to
the control slope over the first 3 mmn) as a function of
concentration of the inhibitor (Maidorn et al.. 1993).
Cell survival experiments
Cell survival was assessed by measuring the colony-forming
efficiency of cells treated with different doses of agents, at
varying pH, values and after different exposure times. Cells
were detached from flasks and exposed to drugs in pH-
adjusted media at a concentration of 106 cells ml-'. as des-
cribed previously (Newell & Tannock, 1989; Maidorn et al..
1993). There was a variation of about 0.1 pH units in the
medium during 6 h of incubation. Following exposure to the
agents, serial dilutions of the cells were plated in triplicate in
Petri dishes containing x-MEM + 5% FCS. and incubated
for 9-11 days. The dishes were stained with methylene blue
and colonies containing more than about 50 cells were
counted. Relative plating efficiency (RPE) was expressed as
Spheroid experiments
Spheroids provide a model of intermediate complexity
between solid tumours and tissue culture which allow the
assessment of cell-cell interactions and tissue penetration of
drugs. In order to examine tissue penetration of HMA and
nigericin. cell killing in intact and dissociated EMT-6
spheroids was determined using a colony-forming assay.
About 2 x 106 EMT-6 cells were seeded into uncoated Petri
dishes and grown overnight. Cell aggregates were transferred
into glass spinner flasks containing 200 ml of complete a-
MEM supplemented with 15% FCS. The medium was
changed 3-4 days after seeding and daily thereafter. After
spheroids attained an average diameter of 600pm (approx-
imately 2 weeks after seeding). they were used in experiments.
After rinsing with PBS. some of the spheroids were
resuspended in 50 ml of pH-balanced medium (pH, = 6.45)
(as intact spheroids). Other spheroids were dissociated by
continuous agitation in 0.025% trypsin and 0.01% EDTA
for 10-12 min at 37C. The resulting cell suspension was
centrifuged and resuspended in 5 ml of pH-balanced medium
(pH, 6.45) at a final concentration of 106 cells ml-' (as
dissociated spheroids). All the samples were placed in a 37°C
water bath. Humidified gas (500 carbon dioxide and air
balance) was used to stabilise the pH of the medium, which
remained within 0.1 units of the initial value during the
exposure period. After 60 min equilibration. drugs were
added (nigericin. 0.25 jg ml-' HMA. 40gm). Control samples
received equal volumes of the diluent. Samples were removed
after different time intervals. Intact spheroids were then dis-
socicated as described above. All the samples (intact and
dissociated) were centrifuged. resuspended in fresh a-
MEM + 5% FCS and counted electronically. diluted serially
and plated in triplicate. After 9-11 days. plates were stained
and colonies containing more than about 50 cells were
counted. Relative plating efficiencies were determined as des-
cribed above.
Since the above method measures only the average effect
of drugs against cells in spheroids. the DNA-binding fluores-
cent dye Hoechst 33342 and fluorescence-activated cell sor-
ting (FACS) were used in further experiments to examine cell
survival at different depths in the spheroids (Durand. 1986.
1990). EMT-6 spheroids. prepared as described above. were
allowed to sediment to the bottom of the flasks. The medium
was removed by aspiration. and spheroids were then
resuspended in 50 ml of pH-balanced medium (pHe 6.45) and
placed in small spinner flasks in a 37'C water bath.
Humidified gas (5% carbon dioxide and air balance) was
used to stabilise the pH of the medium. After 60 mmn equili-
bration. drugs were added (nigericin. 0.25;g ml-': HMA.
50 jLM). Control samples received equal volumes of the vehi-
cle. At the end of 4.5 h drug treatment. spheroids were
exposed to Hoechst 33342 to allow the establishment of a
decreasing fluorescence gradient with increasing depths into
spheroids (Durand. 1986). In preliminary experiments we
found that an exposure time of 25 min to 5 iLM Hoechst
33342 led to optimal separation of cells (on the basis of
Hoechst fluorescence) in different regions of spheroids. At the
end of the exposure. spheroids were allowed to sediment to
the bottom of the collection tubes. Excess drugs and stain
were removed by aspiration of the medium. After washing
with PBS. the spheroids were dissociated by using 0.025%
trypsin and 0.01% EDTA at 37°C for 10-12min with con-
tinuous agitation. The resulting single-cell suspensions were
then centrifuged and resuspended in fresh a-MEM + 5%
FCS and maintained on ice during the sorting procedure.
Cells were sorted on the basis of their fluorescence inten-
sity. which reflects their position in spheroids. Fluorescence-
activated cell sorting utilised a Coulter EPICS V System
(Hialeah, FL, USA) with an argon laser. The green
fluoresence signal was processed through logarithmic
amplifiers and generated a fluorescent profile which wasINHIBITION OF pH REGULATION 619
integrated (LIGF - log integrated green fluorescence) to
establish four windows separating equal numbers of cells.
The whole cell populations were used in both control and
drug-treated samples. Samples were sorted into four fractions
of equal numbers of cells (- 5 x 10 cells in 5 ml). Sorted
cells were then diluted serially and plated in triplicate to
assess survival as described above. The plating efficiency (PE)
of the four fractions of all the samples and relative plating
efficiency (RPE) of the four fractions of drug-treated samples
relative to the four corresponding fractions of control sam-
ples were calculated.
Pharmacokinetics ofHMA in mice
The pharmacokinetics of HMA was studied in Balb/c mice.
Animals were injected intraperitoneally with 20jigg-' HMA.
(The maximum tolerated dose of HMA is about 30 pg/g.)
Mice were anaesthetised and blood samples were obtained by
cutting the neck and collecting into Eppendorf tubes (con-
taining about 100 USP units of heparin per tube) at 2.5, 5,
15, 30, 60, 90 and 180min post injection; the samples were
then centrifuged at 1,000g for 10 min at 4C. Plasma samples
were obtained by pooling blood from 2-4 mice at each of
the times. The same amount of internal standard, 100 ng of
benzamile, was added to each I ml sample to compensate for
any loss of HMA in the extraction procedure and for vanra-
tion in the injection volume.
A solid-phase extraction method described by Alliegro et
al. (1992) was used to prepare the samples. Plasma samples
were applied to I ml C8 preparative solid-phase columns
(Bond Elute: Varian, Harborcity, CA, USA), which had been
pretreated twice with I ml of absolute methanol and rinsed
three times in I ml of distilled water. After sample applica-
tion, the columns were washed twice with I ml of distilled
water, dried by aspiration and eluted with 350jp1 of elution
buffer (20% acetonitrile/45% methanol/4% glacial acetic acid
buffered to pH 4.5 with triethylamine). The eluates were
collected in Eppendorf tubes. After evaporating the solvent
in a speed vacuum, samples could then be stored at - 20C
or processed immediately. Samples were reconstituted into
135pl of 50% methanol, and filtered through a 0.22pm, low
protein binding cellulose acetate cartridge (Spin-X) prior to
HPLC analysis (100pl of each treated sample was injected
into the column).
An isocratic method described by Meng et al. (1990) was
used for HPLC analysis: experiments were performed with a
Waters system, which consisted of a Waters model 6000A
solvent-delivery system (Waters, Milford, MA, USA), two
Waters model 510 HPLC pumps, a Waters model U6K
universal liquid chromatograph injector and a Bio-Sil ODS-
5S 250 mm x 4 mm i.d. (5pm particle size) C,8 reversed-
phase column (Bio-Rad, Richmond, CA, USA) maintained
at a constant temperature of 35'C with a Waters column
heater. A Waters Series 440 UV absorbance detector was
operated at 365 um, and a Shimadzu CR501 integrator
(Shimadzu, Kyoto, Japan) was employed. The mobile phase
was 48% (v/v) acetonitrile in 0.15 M perchloric acid at
pH2.38. The flow rate was 1.lmlmin-'.
In order to verify that the compound extracted from
mouse plasma was HMA, the retention time of the peak
following plasma extraction was first compared with that of
an HMA standard and was found to be identical. Secondly,
HMA was added to the plasma sample, and resulted in
increased amplitude of the single peak. Thirdly, control
plasma injected into the HPLC system did not give rise to a
peak with the same retention time as HMA, indicating that
the injection medium did not contain compounds which co
elute with HMA.
A standard curve relating peak area to concentration was
constructed by adding different amounts of HMA to fixed
volumes of murine plasma. In each plasma sample, the same
amount of the internal standard (benzamile 100ng) was
added. The ratio of the areas under the HMA and benzamile
peaks was used to construct the standard curve for each
experiment. This calibration curve was then used to estimate
the concentration of HMA in samples of plasma, and to
define the relationship between plasma concentration and
time following injection of HMA in Balb/c mice.
Therapeutic effects ofmice
In vivo experiments were performed using the EMT-6 murine
transplantable sarcoma in Balb/c BYJ mice. About 106 EMT-
6 cells in 0.2 ml of a-MEM without FCS were injected intra-
muscularly into the left hind legs of Balb/c mice. After about
7 days, when the tumours had grown to about 1 g, the mice
were injected intraperitoneally with either 1.25 pg g-'
nigericin, lOpg g-' HMA, or nigericin and HMA in com-
bination. Some mice also received hydralazine (1Opgg-
i.p.), which leads to arterial vasodilatation in normal tissues
and has been shown to cause hypoxia and/or a fall in pH in
tumours (Okunieff et al., 1989; Kalmus et al., 1990; Horsman
et al., 1991). Control mice received vehicle solutions. The
tumour-bearing left hind legs of some mice were also
irradiated with 15 Gy of X-rays to kill selectively the aerobic
and possibly less acidic subpopulation of the tumours. Drug
treatments started 30 min after irradiation. Multiple dose
experiments were also carried out in some mice which were
given three i.p. injections (2 h interval) of 0.45 pg g'
nigericin and 4pg g-I HMA.
The survival of cells in the drug-treated tumours was
determined by use of an in vivo-in vitro excision assay. At
20-24 h after treatment, mice were killed by cervical disloca-
tion. Tumours were excised, weighed and then minced with
scissors in PBS. They were treated with trypsin (00 pLg ml-')
and DNAseI (lOpgml'l) at 37'C for 30min to obtain
single-cell suspensions. The resulting cell suspensions were
then passed through a nylon filter to remove undigested
clumps of cells, centrifuged and resuspended in PBS. The
number of viable cells in the suspension was determined by
staining the cells with trypan blue and dye-excluding cells
were counted with a haemocytometer. Tumour cell suspen-
sions were diluted and plated in six-well plates (Nuncton,
Denmark). After 7 days, the plates were stained and colonies
were counted. From the number of cells recovered per gram
of tumour and the plating efficiency of the cells, surviving
fraction per tumour was calculated.
Results
Inhibition ofthe Na+/H+ antiport activity
In initial experiments, we studied the inhibition of the Na+/
H+ antiport by amiloride, EIPA and HMA in EMT-6 cells
using BCECF and fluorometry (Figure 1). From the concent-
ration to give 50% inhibition (IC5o) of the antiport, HMA
and EIPA were about 100 times more potent than amiloride
in EMT-6 cells. The IC50 of HMA in EMT-6 cells was
-40 nM; and > 90% inhibition was observed at concentra-
tions above 1 pM. In limited experiments to study the effect
of Na+/H+ inhibition on cellular uptake of 'Na' we found
that 1 ILM HMA was as effective as 100pM amiloride in
providing >90% inhibition (data not shown). Similar results
were observed in KHT cells (data not shown).
In vitro cytotoxicity ofHMA in monolayer cell culture
Previous experiments have suggested that amiloride and
EIPA are toxic to cells at low pH, ifcells are first exposed to
an agent that causes acidification of the cytoplasm (Maidorn
et al., 1993). Therefore, to assess the in vitro cytotoxicity of
amiloride, EIPA and HMA, survival experiments were per-
formed with varying doses, pH, values and exposure times in
the presence (or absence, for HMA only) of nigericin at
0.25pgml-'.
Nigericin caused cell killing only at pHM below 6.4 (Figure
2). HMA, at a concentration as low as 1pM, was able to
increase the cytotoxicity of nigericin and to extend the range620 J. LUO & I.F. TANNOCK
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Figure 1 Activity of the Na- H- exchanger of EMT-6 cells
exposed to varying concentrations of amiloride (0). EIPA (*) or
HMA (A). Points. mean of two measurements: error bars. range.
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Figure 3 a. Relative plating efficiency (RPE) of EMT-6 cells
treated for 4.5 h with different doses of amiloride. EIPA or HMA
in the presence (or absence, for HMA only) of 0.25 1tg ml-'
nigericin at pH,, 6.5. b. Relative plating efficiency (RPE) of
EMT-6 cells treated for varying times with a given dose of
amiloride. EIPA or HMA in the presence (or absence, for HMA
only) of 0.25 g ml-' nigericin at pH, -6.5. Points. means of
measurements from two independent experiments; error bars.
range of mean values.
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Figure 2 Relative plating efficiency (RPE) of EMT-6 cells
treated with HMA (I pM) alone (0) or nigericin (0.25 gLg ml-')
alone (0) or both (0) for 4.5 h in relation to pH, of the
exposure medium. Points. means of measurements from two
independent experiments: error bars, range of mean values.
of permissive pH, to - 6.8, while HMA alone failed to
achieve any cytotoxicity. Nigericin and HMA, at concentra-
tions of 0.25 Lg m1-' and 1iM respectively, showed approx-
imately a 10-fold decrease in cell survival for every 0.15 units
decrease of the pH, in the range of 6.2-6.8 (Figure 2).
The dose-response relationship for cell killing at pH, 6.5
is shown in Figure 3a. Nigericin alone had a small effect
(surviving fraction 0.7). Amiloride, EIPA and HMA gave a
dose-dependent increase in the cytotoxicity of nigericin, but
EIPA and HMA were about 100 times more potent than
amiloride, similar to their relative potencies for inhibition of
the Na+/H+ antiport (Figure 1). Without nigericin, HMA
alone gave almost no cell killing (Figure 3a). There was no
plateau effect at high concentrations for any of the agents,
even though smaller concentrations of HMA and EIPA
(1 ;M) can achieve effective suppression of the Na+ H+
exchanger activity (Figure 1).
The relationship between exposure time and cytotoxicity at
pH, -6.5 is shown in Figure 3b. Nigericin (0.25tgg ml-')
alone gave a surviving fraction of -0.1 after 6 h exposure.
When amiloride, EIPA or HMA was used in combination
with nigericin, they all increased the cytotoxicity of nigericin
for any given exposure time. Time-dependent survival curves
were similar for nigericin used with 100 gM amiloride, 1iM
EIPA or 1I M HMA (Figure 3b). Nigericin (0.25 gml-')
plus 10 iM HMA led to higher levels of cytotoxicity than
nigericin (0.25 ,Lg ml-') plus 1 iLM HMA, again demons-
trating the absence of a plateau effect for cell killing.
Cell killing in intact and dissociated spheroids
Further experiments were performed with the potent
inhibitor of Na+/H+ exchange, HMA. To determine whether
HMA has good tissue penetration, the cell killing effect of
nigericin and HMA was compared in intact and dissociated
EMT-6 spheroids. The results of experiments which compare
the time course of cell survival in intact spheroids and in cells
obtained from their prior dissociation are shown in Figure 4.
Cells in intact and dissociated spheroids treated with
nigericin alone or with HMA alone showed limited cytotox-
icity when exposed to these agents in medium at pH, 6.45.
HMA increased the cytotoxicity of nigericin for both intact
spheroids and for cells from dissociated spheroids. Greater
cell killing was observed in the dissociated than in the intact
spheroids, but, since cell survival after 4.5 h incubation was
reduced to < 10-2 in intact spheroids treated with nigericin
and HMA, both agents can penetrate through layers of tissue
to kill the internal cells. To obtain similar level of cytotox-
icity to those observed for cells in monolayer culture, higher
doses (40 gM) of HMA were required for treatment of
spheroids, and for treatment of cells immediately after dis-
sociating spheroids (compare with Figure 3b). Thus, cells in
spheroids are more resistant to drug treatment than single
cells in culture.
A further experiment was carried out in which cells
obtained by dissociating spheroids were plated in Petri dishes
for 3 days (until confluent), and then treated with nigericin
and HMA. The sensitivity of these cells to drug treatment
recovered to a level that was only slightly less than that of
the original cultured cells (data not shown).
Cell killing at different depths in spheroids
In order to examine drug effects at different depths in
spheroids, cells were obtained from drug-treated EMT-6
spheroids (treated at pH, 6.45 with 50 gM HMA,
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Figure 4 Relative plating efficiency (RPE) of intact (I) or dis-
sociated (D) EMT-6 spheroids treated for varying times with
40 gum HMA or 0.25 8g ml-' nigericin or both drugs at pH, 6.45.
Control samples were treated with diluent. Points, means of
measurements from two independent experiments; error bars,
range of mean values.
0.25 tg ml-' nigericin. alone or in combination) that were
exposed to Hoechst 33342. These cells were sorted by FACS
into four equal fractions with the same number of cells in
each fraction. Fractions 1 (dimmest) to 4 (brightest)
represented the cells from inner to outer regions of the
spheroids. The ratio of mean Hoechst 33342 fluorescence in
the brightest and dimmest fractions was about 18 in the two
independent experiments that were used to assess cell sur-
vival. Cell recovery from the spheroids after drug treatment
was -88%. The PE of the inner fraction was somewhat
lower than the other three fractions. indicating that there
were less viable cells in this region (data not shown). In order
to correct for this effect. RPEs of the four fractions of
drug-treated samples relative to the four corresponding frac-
tions of control samples were calculated and are shown in
Figure 5. HMA alone showed little or no cytotoxicity, and
nigericin alone caused minimal cytotoxicity in these four
fractions. When nigericin was used in combination with
HMA. the cytotoxicity in each of the four fractions was
markedly increased. There were at most small differences in
the level of cell survival in these four fractions, indicating
that nigericin and HMA can penetrate through layers of
tissue in the spheroids to give similar cell killing at different
depths of penetration.
Pharmacokinetics ofHMA in Balb c mice
The concentration of HMA in mouse plasma was determined
by HPLC. To construct a standard curve, plasma samples
containing different concentrations of HMA with the same
amount of benzamile added were analysed (Figure 6a). The
ratio of the areas under each HMA and benzamile peak was
plotted against HMA concentration. The standard curve was
linear over the range of HMA concentrations (0.1--50 M)
that might be expected to be present in mouse plasma, and
the correlation coefficient was 0.999 (Figure 6a). The sen-
sitivity of the method allows detection of about 0.1 AM HMA
in plasma.
The plasma concentration-time curve for HMA in Balb c
mice averaged from two independent experiments is shown in
Figure 6b. Immediately after injection of an i.p. dose of
20 gg g', the concentration of HMA in plasma increased
and reached a peak level of 8 jAM at about 15 min.
Thereafter, the concentration of HMA decreased at a rate
that approximates a monoexponential decay. From the curve,
it is estimated that the half-life (the time at which half of the
initial concentration is reached) of HMA in Balb c mouse
plasma is about 35 min. At about 120 mmn after injection, the
concentration of HMA in plasma decreased to 1 gM. which
corresponds to the lowest effective concentration of HMA
(when combined with nigericin) which led to cytotoxicity for
EMT-6 cells in monolayer culture (see Figure 3a).
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Figure 5 Relative plating efficiency (RPE) in different fractions
of cells from EMT-6 spheroids. stained with Hoechst 33342 and
separated by FACS. Fraction I represents the inner region (dim-
mest) and fraction 4 the outer region (brightest). Spheroids were
exposed to drugs or diluent for 4.5 h at pHe 6.45. Columns.
means of measurements from two independent experiments; error
bars. range of mean values. = . HMA (50 AM); M. nigericin
(0.25 g ml-'): M. nigericin + HMA.
co
0
co
c
U,
10
-i
a
0
U1
c
0
u
Al1
0 100 200
Time (min)
Figure 6 a. Standard curve which characterises the quantitation
of HMA in Balb c mouse plasma, as detected by HPLC. The
ordinate indicates the ratio of the area under the HMA peak to
that under a standard (100 ng of benzamile) peak. b. The plasma
concentratio'n-time curve of HMA in Balb c mouse plasma fol-
lowing an i.p. injection of 20 Lg g-' HMA. Points. means of
measurements from two independent experiments: error bars.
range.
In vivo effects ofnigericin and HMA on the EMT-6 tumour
In preliminary experiments we determined that mice tolerated
doses of 2.5 jig g-' nigericin alone, 30jlg g-1 HMA alone or
a combination of 1.25;g g-1 nigericin and 10lg g1 HMA.
At higher doses death of mice after 24 h was observed (Data
not shown).
Multiple experiments were performed to determine the sur-
viving fraction per tumour (SF/tumour) following treatment622 J. LUO & I.F. TANNOCK
of mice with either one. two or all three of the drugs hyd-
ralazine, nigenrcin and HMA (Figure 7). When mice bearing
EMT-6 tumours were treated with HMA alone, hydralazine
alone or two of the three drugs in combination, cytotoxicity
was minimal. Only the combination of the three drugs
(10 ggg-' HMA + 1.25;Lgg-' nigericin plus 10igg-' hyd-
ralazine) led to a SF/tumour of less than 10-2. In comparison
with control, the recovery of dye-excluding cells per gram of
tumour was about ten times lower following treatment with
three drugs in combination. The result of an experiment in
which mice were given three injections of nigericin and HMA
at 2 h intervals is also shown in Figure 7; multiple doses of
nigericin and HMA failed to show significant in vivo cytotox-
icity. We did not investigate the use of multiple doses in
combination with hydralazine.
In further experiments. tumour irradiation was used to
select a population of hypoxic and presumably acidic cells.
The results of experiments which determined the SF tumour
of the above agents used with and without radiation are
shown in Figure 8. Radiation (15 Gy) led to a surviving
0.1
0
E
0.001
Fige 7 Surviving fraction per tumour (SF tumour) for the
EMT-6 tumour folloWing the indicated treatments. Columns.
means of independent estimates from 3-7 mice: error bars. stan-
dard deviations. O. HMA (10 g g-'): M. hydralazine
(l0Ogg-')+HMA (lOAgg-'); ES. hydralazine (10;gg-').
M. hydralazine (10 jg g-') + nigericin (1.25 ig g-'): M.
nigericin (1.25 gIg gl') + HMA (10 jg g-'); L. three injections
(2 h interval) of HMA (4lg gg') + nigericin (0.45Ag gg') for
each injection; . hydralazine (10 Mg g1 ') + nigenrcin
(1.25 fg g-') + HMA (10A gg').
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Figure 8 Survi-ing fraction per tumour (SF tumour) of the
EMT-6 tumour folloWing 15 Gy radiation. either alone or with
drugs given 30 min after radiation treatment. Columns. means of
independent estimates from 3-7 mice: error bars. standard devia-
tion. radiation (15 G): M. radiation (15 Gy) + HMA
(O10g g'); M. radiation (15 Gy) + hydralazine (lO1g g- l);
. radiation (15 Gy) + hydralazine (l10igg') + nigericin
(1.25MLgg-') E. radiation (15Gy)+hydralazine (IO0g
g-')+HMA (O1g0gg-'): L. radiation (15Gy)+nigericin
(1.25Lgigg')+HMA (10gigg'): . radiation (15Gy)+
hydralazine (lO1gg-')+ nigericin (l.25Lggg') + HMA (1O0Lg
g- ).
fraction of - 10--. When radiation was followed by
10 lg g` HMA there was no significant increase in cell
killing. When radiation was followed by hydralazine. or by
the combinations of two of the three drugs (e.g. nigencin + -
HMA). there was a reduction in cell survival to about
2 x I0-3. The toxicity of radiation followed by all three of
the drugs in combination (hyralazine. HMA and nigericin)
decreased the level of cell survival to about 10'. However.
the effect of these drugs used in combination with radiation
was no greater than the sum of the effect of the three drugs
in combination and that of radiation alone (additive model).
Discussion
Under the microenvironmental conditions found within the
acidic regions of solid tumours. the Na+ H+ antiport was
found to be an important and perhaps dominant mechanism
for regulation of pHi (Boyer & Tannock. 1992). Function of
the antiport also appears to be required for the growth of at
least one type of solid tumour (Rotin et al.. 1989). Previous
experiments have shown that amiloride. in combination With
cell-acidifying agents (e.g. nigericin. CCCP). causes cytotox-
icity at low pHe in tissue culture (Rotin et al.. 1987: Newell &
Tannock. 1989). Furthermore. EIPA and other potent
amiloride analogues can cause a higher level of cytotoxicit)
than amiloride (Maidorn et al.. 1993). The present study
demonstrates that HMA and EIPA increased the cytotoxicity
of nigericin to a similar extent: both are - 100 times more
potent than amiloride in causing pHe-dependent cytotoxicity
(Figures 2 and 3). The relative potency of amiloride
analogues in causing cytotoxicity correlates with their relative
potency in inhibition of the Na+ H+ antiport (Figure 1).
suggesting that inhibition of the Na+ H+ antiport. rather
than other non-specific effects. is largely responsible for the
cytotoxicity of these agents at low pH,. More convincing
evidence came from the studv of Maidorn et al. (1993) in
which EIPA did not increase the cytotoxicity of nigericin in a
mutant cell line. PS-120. which lacks the Na' H+ antiport.
The cell-acidifying agent nigericin causes cytotoxicity only
under condition of pH, below 6.5. HMA extended the per-
missive range ofpH, to <6.8 (Figure 2). In 'ivo. estimates of
pH, below 6.8 have been recorded in solid tumours. but not
in most normal tissues. This result provides the basis for the
potential selectivity of HMA in killing cells within the acidic
microenvironment of solid tumours.
Although the concentrations of HMA and EIPA required
to give maximal inhibition of Na+ H+ antiport activitv were
about 1 g.m. there was a continuous fall in cell survival within
the dose range of HMA and EIPA tested (Figure 3a). Failure
to observe a maximum level of cell killing may occur because
the survival of cells was assessed after a 4.5 h exposure to
nigericin and HMA. whereas inhibition of the Nat H+
antiport was determined over a period of several minutes
(Figures 1-3). Also. the experiments which quantitate inhibi-
tion of Na+ H+ exchange activity (Figure 1) might be insen-
sitive to small changes within the range of 90-100% inhibi-
tion. and we cannot exclude some additional toxic effects due
to other non-specific mechanisms.
The potential of nigericin and HMA to cause anti-tumour
effects in isvo depends on their ability to penetrate tissue. and
this effect was studied in spheroids. Although there was
greater cell killing in dissociated spheroids than in intact
ones. a high level of cell killing in intact spheroids was still
observed. suggesting that both agents can penetrate through
layers of tissue to kill the inner cells. The possible reasons for
failing to observe the same level of cell killing in intact and
dissociated spheroids include: (a) cells from dissociated
spheroids and cells in intact spheroids may have different
sensitivity to the drugs because of factors related to cell
contact or to the microenvironment: (b) dissociation of
spheroids using trypsin and gentle mechanical disaggregation
may make the cells more sensitive to the drug treatment:
and or (c) there may be minor problems with drug penetra-
tion. such that the average concentration of drugs in theINHIBITION OF pH REGULATION 623
central region of intact spheroids is lower than in the outer
regions.
Higher concentrations of HMA (40-50gM) were required
to achieve similar cytotoxicity in intact spheroids or cells
immediately dissociated from spheroids as compared with
cells maintained in monolayer culture (1-10IM) (compare
Figures 3 and 4). Thus, cells in EMT-6 spheroids and cells
immediately dissociated from them are more resistant to drug
treatment. Additional experiments (data not shown) revealed
that cells first dissociated from spheroids and then plated for
3 days (until confluent) became almost as sensitive to the
drug treatment as the original cultured cells. Spheroids have
been reported to be more resistant to treatments with ionis-
ing radiation, heat, ultrasound and doxorubicin (Dertinger &
Huesler, 1981; Durand, 1981; Sacks et al., 1981; Wigle &
Sutherland, 1985). Resistance to ionising radiation in Chinese
hamster V79 lung cells was found to persist for about one
cell cycle (10 h) after dissociation of the spheroids (Durand &
Sutherland, 1972). Sutherland (1988) suggested that a history
of growth in close cell-cell contact is the most important
factor for such phenomena, and that direct cell-cell com-
munication at the time of treatment may not be critical for
the 'contact effect'. For treatment with agents that act on the
cell surface such as nigericin and HMA, cell contact might
inhibit the effects of drugs to cause acidification (nigericin) or
limit access to Na+/H+ antiport proteins (HMA). Relative
resistance might also occur if the activity of these drugs was
dependent on cell proliferation, since many cells in spheroids
may be out of cycle.
Since the above method measured only the average cell
killing in spheroids, fluorescence-activated cell sorting
(FACS) was used to determine cytotoxicity as a function of
depth throughout the spheroids. A high concentration of
HMA (50gM) was used in such experiments because of
resistance of spheroids to the drug treatment. Only minor
differences in cell survival were observed in the four sorted
fractions (Figure 5), suggesting that HMA can penetrate
through spheroids and can give similar cell killing at different
depths. However, because of spherical geometry, the sorting
ofcells from spheroids into four equal fractions does not rule
out minor problems of penetration to the deepest viable cells.
Spheroids used in experiments had a mean diameter of
-6001im, and would have a necrotic centre of diameter
-200 im. Separation of the viable regions into four equal
fractions then leads to shells of thickness of - 190pm (inner-
most), - 90 lim,
- 65gm and - 55pm (outermost). Varia-
tions in sensitivity to the drugs in the innermost shell cannot
be excluded by this method. When spheroids are grown at
physiological pH, there is evidence for a lower pH, in the
central region (Carlsson & Acker 1988). We were not able to
measure pH, in our spheroids, but it is possible that central
regions had lower pH, than peripheral regions even when the
pH, of the medium was - 6.5. Thus, failure to observe
differences in cell killing among the sorted fractions might
have been due to opposing effects of (i) a modest barrier to
penetration and (ii) increased sensitivity of internal cells.
Pharmacokinetic studies are required to derive strategies to
deliver and maintain a desirable concentration of HMA in
vivo. Accordingly, a sensitive HPLC method was developed
to quantitate plasma levels of HMA in the Balb/c mouse.
The plasma concentration-time curve of HMA (Figure 6b)
showed that the peak concentration was about 8 Mm after i.p.
administration of a single dose of 20jugg9'. The elimination
half-life was estimated as 35 min. The plasma concentration
of HMA was reduced below 1 gM after approximately
120 min. These results, in conjunction with previous results
from this laboratory (Newell et al., 1992) which showed
reduction of p1 in vivo within 2 h after i.p. injection of
nigericin, suggest that in vivo killing of cells is feasible if cells
in vivo have similar sensitivity to those in monolayer culture.
Greater cell killing at tolerated doses might be achieved by
delivering drugs by constant infusion to maintain plasma
levels at a constant value for several hours.
The present study showed that HMA and nigericin could
achieve effective cell killing below pH, 6.8 in vitro. Newell et
al. (1992) reported that the average pH, of EMT-6 tumours
grown in the legs of mice is about 6.75 (about 0.3 pH units
below muscle pH,); pH, is expected to depend on location
relative to blood vessels, with lower pH, at increasing dis-
tance from blood vessels. However, cytotoxicity was not
observed when single or multiple doses of HMA and
nigericin were administered in vivo (Figure 7). The failure to
observe cytotoxicity probably occurs because at doses of
HMA and nigericin which can be achieved in vivo the pH, in
most regions of tumours is too high to obtain selective cell
killing. It is probable that spheroids provide a better model
for tumours than single cells in culture, and that relative drug
resistance may be expected from cells in contact in the in vivo
environment.
It has been shown that hydralazine can cause a reduction
in tumour blood flow and oxygen delivery (Lin & Song,
1990; Chaplin et al., 1991; Peters & Chaplin. 1992). The
effect is thought to occur because blood vessels in normal
tissues dilate, whereas those in tumours lack smooth muscle
and consequently will not respond to agents which act on
vascular smooth muscle. We and others have found that
hydralazine may lead to a modest reduction in mean pH,
and/or pH- of tumours (Okunieff et al., 1989). Hydralazine
was found to potentiate the cytotoxicity of nigericin and
HMA in EMT-6 tumours (Figure 7), and values of SF,
tumour were reduced to below 10-'. The possible
mechanisms for such potentiation include the following
1. reduction in tumour pH, leading to increased cytotoxicity
of these acid-dependent agents;
2. alteration of drug pharmacokinetics;
3. direct interaction of hydralazine with HMA and nigericin
to potentiate cytotoxicity;
4. combined effects of hypoxia and reduced pH, to enhance
cell killing by drugs.
The use of a high concentration of hydralazine
(5OMgml-') does not increase the cytotoxicity of nigericin
and EIPA in vitro (K. Hasuda & I. Tannock, personal com-
munication), indicating that a direct interaction is unlikely to
be the mechanism responsible for the potentiation of cytotox-
icity observed in vivo. Rotin et al. (1986) reported that the
combination of hypoxia and acidity could cause higher
cytotoxicity to cells than acidity alone, probably because
both factors lead to ATP depletion. Thus, the combination
of hypoxia and acidity caused by hydralazine could be a
mechanism responsible for the observed potentiation of
nigericin and HMA (Figure 7). Consistent with the above
interpretation, experiments in our laboratory have shown
that glucose injection caused a greater reduction in tumour
pH, than administration of hydralazine, but was less effective
in potentiating the cytotoxicity of nigericin and EIPA than
hydralazine (K. Hasuda & I. Tannock, personal communica-
tion). Hydralazine may cause both hypoxia and reduced pH1,
whereas glucose acts mainly to reduce p1. Finally, a vasoac-
tive agent such as hydalazine will influence the delivery and
removal of drugs to and from the tumour. It is probable that
multiple mechanisms are responsible for the potentiation by
hydralazine of the cytotoxicity of nigericin plus HMA.
Since hypoxic and acidic subpopulations of tumour cells
are likely to be more sensitive to drug treatment, experiments
were also performed with radiation (before drug treatment)
to deplete aerobic and putatively less acidic tumour cells. The
toxic effects of hydralazine, nigericin and HMA appeared to
be additive with those of radiation and do not suggest selec-
tive toxicity towards cells in the hypoxic/acidic microenviron-
ments of solid tumours. This effect might occur because
significant toxicity of nigenrcin and HMA requires the
presence of hydralazine, which even in the absence of radia-
tion enlarges the hypoxic and acidic subpopulations; in effect,
both hydralazine and radiation may be selecting a hypoxic
and acidic subpopulation. It is also possible that the sub-
populations of hypoxic cells and acidic cells in tumours are
discrete, since hypoxia may occur adjacent to regions of
necrosis, whereas necrotic regions of tumours have been
reported to be slightly alkaline (Kallinowski & Vaupel, 1988).624 J. LUO & I.F. TANNOCK
Acute hypoxia may also occur in non-acid regions owing to
rapid fluctuations in blood flow. These effects would imply
the potential for therapeutic benefits from combining agents
that are selectively toxic under hypoxic and under acidic
conditions.
The results of the present studv indicate that HMA. in
combination with nigericin and hydralazine. can lead to
death of cells in solid tumours. This effect is probably due in
part to inhibition of regulation of pH, under the environmen-
tal conditions that occur in solid tumours. Additional
strategies which maximise the pH, differential between
tumours and normal tissues, and which inhibit bicarbonate-
based mechanisms of pHi regulation. may allow the develop-
ment of acid-mediated selective tumour therapy.
Abbrevations
BCECF-AM. 2'. 7'-bis-(2-carboxyethyl)-5-(and 6)-carboxyfluorescein
acetoxymethylester; CCCP. carbonylcyamide-3-chlorophenylhydra-
zone: EIPA, 54N-ethyl-N-isopropyl) amilonrde; FACS, fluorescence-
activated cell sorting; HMA. 5-(N,N-hexamethylene) amiloride;
HPLC. high-performance liquid chromatography; IC5., half-maximal
inhibition concentration; i.p.. intraperitoneal; LIGF, log integrated
green fluorescence: NMG. N-methyl-D-glucamine; PBS, phosphate-
buffered saline: PE, plating efficiency. pH,. extracellular pH; pH
intracellular pH; RPE, relative plating efficiency; SF tumour: survival
fraction per tumour; cm-MEM. a-minimal essential medium.
This study was supported by a research grant from the Medical
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